Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Anti-angiogenic Effect of Cryptotanshinone through Inhibition of HIF-1alpha and STAT3 in Prostate Cancer Cells

단삼 유래 단일 물질 cryptotanshione의 전립선 암주에서의 HIF-1alpha와 STAT3 억제를 통한 신생혈관억제효과

  • Received : 2012.07.06
  • Accepted : 2012.08.20
  • Published : 2012.08.25
Download PDF
⟨ Previous Next ⟩

Abstract

Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that regulates various cellular processes such as cell survival, angiogenesis and proliferation. In the present study, we examined that Cryptotanshione(CT), a tanshinone from oriental traditional medicinal herb Danshen (Salvia miltiorrhiza Bunge), had the inhibitory effects on hypoxia-mediated activation of STAT3 in androgen independent human prostate cancer PC-3 cells. CT inhibited the protein expression of hypoxia-inducible factor-1alpha (HIF-$1{\alpha}$) under hypoxic condition. Consistently, CT blocked hypoxia-induced phosphorylation and nuclear accumulation of STAT3. In addition, CT reduced cellular of vascular endothelial growth factor (VEGF), a critical angiogenic factor and a target gene of STAT3 induced under hypoxia. Of note, chromatin immunoprecipitation (ChiP) assay revealed that CT inhibited binding of STAT3 to VEGF promoter. Taken together, our results suggest that CT has anti-angiogenic activity by disturbing the binding STAT3 to the VEGF promoter in PC-3 cells.

Keywords

References

  1. Bowman, T., Garcia, R., Tukson, J., Jove, R. STATs in oncogenesis. Oncogene. 19: 2474-2488, 2000. https://doi.org/10.1038/sj.onc.1203527
  2. Aggarwal, B.B., Sethi, G., Ahn, K.S., Sandur, S.K., Pandey, M.K., Kynnmakkara, A.B., Sung, B., Ichikawa, H. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. 1091: 151-169, 2006. https://doi.org/10.1196/annals.1378.063
  3. Koh, M., Spivak-Kroizman, TR., Powis, G. HIF-1 regulation: not so easy come, easy go. Trend Biochem Sci. 33: 526-534, 2008. https://doi.org/10.1016/j.tibs.2008.08.002
  4. Jung, J.E., Lee, H.G., Cho, I.H., Chung, D.H., Yoon, S.H., et al. STAT3 is a potential modulator of HIF-1 mediated VEGF expression in human renal carcinoma cells. FASEB J. 19: 1286-1298, 2005.
  5. Jung, J.E., Kim, H.S., Lee, C.S., Shin, Y.J., Kim, Y.N., et al. STAT3 inhibits the degradation of HIF-1alpha by pVHLmediated ubiquitination. Exp Mol Med 40: 479-485, 2008. https://doi.org/10.3858/emm.2008.40.5.479
  6. Cheng, T.O. Cardiovascular effects of Danshen. Int J Cardiol. 121: 9-22, 2007. https://doi.org/10.1016/j.ijcard.2007.01.004
  7. Zhou, L., Zuo, Z., Chow, M.S. Danshen : an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J clin Pharmacol. 45: 1345-1359, 2005. https://doi.org/10.1177/0091270005282630
  8. Wojcikowski, K., Johnson, DW., Gobe, G. Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. J Lab Clin Med. 147: 160-166, 2006. https://doi.org/10.1016/j.lab.2005.11.011
  9. Yu, X.Y., Lin, S.G., Chen, X., Zhou, Z.W., Liang, J., Duan, W., et al.Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier. Curr Drug Metab. 8: 365-378, 2007. https://doi.org/10.2174/138920007780655441
  10. Liu, J., Shen, H.M., Ong, C.N.. Salvia miltiorrhiza inhibits cell growth and induces apoptosis in human hepatoma HepG(2) cells. Cancer Lett. 153: 85-93, 2000. https://doi.org/10.1016/S0304-3835(00)00391-8
  11. Shin, D.S., Kim, H.N., Shin, K.D., Yoon, Y.J., Kim, S.J., Han, D.C., et al. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells. Cancer Res. 69: 193-202, 2009. https://doi.org/10.1158/0008-5472.CAN-08-2575
  12. Chen, W., Luo, Y., Liu, L., Zhou, H., Xu, B., Han, X., et al. Cryptotanshinone inhibits cancer cell proliferation by suppressing mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation. Cancer Prev Res 3: 1015-1025, 2010. https://doi.org/10.1158/1940-6207.CAPR-10-0020
  13. Kim, S.H., Ahn, K.S., Jeong, S.J., Kwon, T.R., Jung, J.H., et al. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells. Eur J Pharmacol. 654: 10-16, 2011. https://doi.org/10.1016/j.ejphar.2010.11.032
  14. Mottet, D., Dumont, V., Deccache, Y., Demazy, C., Ninane, N., Raes, M., Michiels, C. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. J Biol Chem. 278(33):31277-31285, 2003. https://doi.org/10.1074/jbc.M300763200
  15. Du, J., Xu, R., Hu, Z., Tian, Y., Zhu, Y., Gu, L., Zhou, L. PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1$\alpha$ expression in MCF-7 breast cancer cells.PLoS one. 6(9):e 25213, 2011. https://doi.org/10.1371/journal.pone.0025213
  16. Zhu, C., Qi, X., Chen, Y., Sun, B., Dai, Y., Gu, Y. PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer. J Cancer Res Clin Oncol. 137(11):1587-1594, 2011. https://doi.org/10.1007/s00432-011-1049-2
  17. Niu, G., Wright, KL., Huang, M., Song, L., Haura, E, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 21: 2000-2008, 2002. https://doi.org/10.1038/sj.onc.1205260
  18. Wei, D., Le, X., Zheng, L., Wang, L., Frey, JA., et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene. 22: 319-329, 2003. https://doi.org/10.1038/sj.onc.1206122